Epidural Oxycodone for Pain Management for Lower Limb Amputation

Launched by KAFRELSHEIKH UNIVERSITY · Feb 17, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of epidural oxycodone, a type of pain relief medication, to help manage pain after a lower limb amputation. The goal is to see how effective this method is in reducing pain for patients who have undergone this type of surgery. The trial is currently looking for participants who are between 18 and 65 years old, of any gender, and who are in a certain health condition (ASA physical status II or III). To be eligible, participants must be having a lower limb amputation and will receive epidural anesthesia during the procedure.

If you or someone you know is interested in participating, you can expect to receive epidural oxycodone for pain relief and be monitored throughout the recovery process. However, it's important to note that individuals with certain health issues, such as allergies to opioids, heart problems, severe breathing issues, or those who are pregnant, cannot participate in this trial. This study aims to provide valuable insights into pain management for patients after amputation, potentially improving their recovery experience.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 to 65 years.
• • Both sexes.
• • American Society of Anesthesiologists (ASA) physical status II or III.
• • Undergoing lower limb amputation.
• • Under epidural anesthesia.
• Exclusion Criteria:
• • Hypersensitivity to opioids.
• • Cardiac arrhythmias.
• • Acute asthma or other obstructive airways disease.
• • Severe renal impairment.
• • Pregnancy.